We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 141-160 of 10,000 results
  1. Comparison of the Impact of Immune-Related Adverse Events Due to Immune Checkpoint Inhibitor Dual Combination Therapy and Immune Checkpoint Inhibitor Plus Tyrosine Kinase Inhibitor Combination Therapy in Patients with Advanced Renal Cell Carcinoma

    Background

    The prognostic impact of immune-related adverse events during immune checkpoint inhibitor-based combination therapy for advanced renal cell...

    Hiroki Ishihara, Yuki Nemoto, ... Toshio Takagi in Targeted Oncology
    Article 26 December 2022
  2. SGLT-2 inhibitors and atrial fibrillation in the Food and Drug Administration adverse event reporting system

    Background

    Sodium glucose cotransporter-2 inhibitors (SGLT2i) reduce the risk of heart failure and new data show they can prevent atrial fibrillation...

    Benedetta Maria Bonora, Emanuel Raschi, ... Gian Paolo Fadini in Cardiovascular Diabetology
    Article Open access 11 February 2021
  3. Increasing serum miR-409-3p predicts the major adverse cardiac adverse events in elderly patients after hip fracture surgery

    Background

    Major adverse cardiovascular events (MACE) are critical complications responsible for the morbidity and mortality of elderly hip fracture...

    Zhengtao Sun, Kai Cheng, ... Jian Jia in BMC Musculoskeletal Disorders
    Article Open access 28 November 2023
  4. Severe cutaneous adverse reactions

    Severe cutaneous adverse reactions (SCARs), which include Stevens–Johnson syndrome and toxic epidermal necrolysis, drug reaction with eosinophilia...

    Shuen-Iu Hung, Maja Mockenhaupt, ... Wen-Hung Chung in Nature Reviews Disease Primers
    Article 25 April 2024
  5. Ventricular-arterial decoupling is associated with in-hospital adverse events in normotensive pulmonary embolism

    During acute pulmonary embolism (PE) a compensatory increase in right ventricular (RV) contractility is required to match increased afterload to...

    Omid Kiamanesh, Graeme Prosperi-Porta, ... Jason Weatherald in The International Journal of Cardiovascular Imaging
    Article 15 July 2022
  6. Emergence of psychiatric adverse events during antipsychotic treatment in AP-naïve children and adolescents

    Background

    Over the last decades, antipsychotic prescriptions in children have increased worldwide. However, adverse events are frequently observed,...

    Marie-Line Menard, Philippe Auby, ... Rochet Thierry in Child and Adolescent Psychiatry and Mental Health
    Article Open access 12 November 2022
  7. Oxygen Uptake Efficiency Slope Predicts Adverse Outcome Following Atrial Switch Procedure

    Prior to the 1990s, d-TGA was palliated with the atrial switch procedure resulting in a systemic right ventricle associated with significant...

    Kelly J. Aarsvold, David A. Danford, Anji T. Yetman in Pediatric Cardiology
    Article 26 October 2021
  8. Evaluating Monitoring Guidelines of Clozapine-Induced Adverse Effects: a Systematic Review

    Background and Objectives

    Despite the evidence that no other antipsychotic is effective as clozapine for the treatment of resistant schizophrenia, it...

    Sarah Smessaert, Johan Detraux, ... Marc De Hert in CNS Drugs
    Article 18 January 2024
  9. Analysis of Reported Adverse Events Associated with Over-the-Scope Endoscopic Suturing System: an FDA MAUDE Database Study

    Purpose

    The over-the-scope endoscopic suturing system (ESS) (OverStitch™) is one of the most widely utilized endoscopic suturing systems in current...

    Natalie Wilson, Mohamed Abdallah, ... Mohammad Bilal in Obesity Surgery
    Article 21 February 2023
  10. Understanding the Medical Dictionary for Regulatory Activities (MedDRA) reporting of herpes simplex virus (HSV) adverse events in atopic dermatitis clinical trials

    Drug efficacy is best evaluated by randomized, controlled, double-blind clinical trials; however, safety is harder to assess. The Medical Dictionary...

    Rachel E. Tao, Jessica N. Pixley, ... Steven R. Feldman in Archives of Dermatological Research
    Article 12 December 2023
  11. Evaluation of Cardiac Adverse Events with Nivolumab Using a Japanese Real-World Database

    Background

    Nivolumab has been used for the treatment of various types of cancers and has achieved improvements in overall survival. However, nivolumab...

    Yuko Kanbayashi, Tadashi Shimizu, ... Mayako Uchida in Clinical Drug Investigation
    Article 13 February 2023
  12. Hospital spending and length of stay attributable to perioperative adverse events for inpatient hip, knee, and spine surgery: a retrospective cohort study

    Background

    The incremental hospital cost and length of stay (LOS) associated with adverse events (AEs) has not been well characterized for planned and...

    Y. Raja Rampersaud, Kala Sundararajan, ... Christian Veillette in BMC Health Services Research
    Article Open access 25 October 2023
  13. A Comprehensive Analysis of Reported Adverse Events and Device Failures Associated with Esophageal Self-Expandable Metal Stents: An FDA MAUDE Database Study

    Introduction

    Esophageal Stents are used to maintain esophageal lumen patency in esophageal strictures caused by intrinsic and/or extrinsic...

    Fouad Jaber, Saqr Alsakarneh, ... Ahmad Najdat Bazarbashi in Digestive Diseases and Sciences
    Article 29 May 2024
  14. Comparative Safety Surveillance of Triple (IDA) Versus Dual Therapy (DA) in Mass Drug Administration for Elimination of Lymphatic Filariasis in Kenya: A Cohort Event Monitoring Study

    Introduction

    Dual diethylcarbamazine and albendazole (DA) therapy is the standard mass drug administration (MDA) regimen for lymphatic filariasis in...

    Christabel Khaemba, Abbie Barry, ... Eleni Aklillu in Drug Safety
    Article Open access 08 August 2023
  15. The psychological impact of adverse events on urology trainees

    Introduction

    Adverse events (AE) are an inevitable reality in healthcare, with an incidence of 7.5–14.1% worldwide. AEs are recognised to cause...

    Sorcha O’Meara, Frank D’Arcy, ... Kilian Walsh in Irish Journal of Medical Science (1971 -)
    Article 03 November 2022
  16. Pharmacovigilance-based drug repurposing: searching for putative drugs with hypohidrosis or anhidrosis adverse events for use against hyperhidrosis

    Background

    Drug repurposing refers to the application of existing drugs to new therapeutic indications. As phenotypic indicators of human drug...

    Yi Liu, Yanguo Liu, ... Lin Huang in European Journal of Medical Research
    Article Open access 24 February 2023
  17. Frailty, gaps in care coordination, and preventable adverse events

    Background

    Older US adults often receive care from multiple ambulatory providers. Seeing multiple providers may be clinically appropriate but creates...

    Oluwasegun P. Akinyelure, Calvin L. Colvin, ... Lisa M. Kern in BMC Geriatrics
    Article Open access 02 June 2022
  18. Adverse events of anti-IL-5 drugs in patients with eosinophilic asthma: a meta-analysis of randomized controlled trials and real-world evidence-based assessments

    Background

    We aimed to clarify comprehensively the safety profiles of anti-IL-5 drugs and pinpoint potential safety concerns that may arise in their...

    Wen Li, Shi-Chao Tang, Lei ** in BMC Pulmonary Medicine
    Article Open access 03 February 2024
  19. Stress hyperglycemia ratio as a prognostic indicator for long-term adverse outcomes in heart failure with preserved ejection fraction

    Background

    Recent studies highlighted that stress hyperglycemia ratio (SHR) is a potential predictor for future risk in heart failure (HF) patients....

    Abdul-Quddus Mohammed, Yongqiang Luo, ... Wenliang Che in Cardiovascular Diabetology
    Article Open access 13 February 2024
  20. Population-Based Observational Study of Adverse Drug Event-Related Mortality in the Super-Aged Society of Japan

    Introduction

    Adverse drug events (ADEs) are a major cause of mortality.

    Objective

    We examined long-term trends for ADE-related deaths in Japan.

    ...
    Tomoko Funahashi, Toshihiro Koyama, ... Mitsunobu R. Kano in Drug Safety
    Article 07 April 2021
Did you find what you were looking for? Share feedback.